Rate My Professor Sarah Donald

Her primary research interests centre on the utilisation and safety of prescription medicines during pregnancy, including patterns of dispensing and potential risks. Additional areas include promoting optimal weight gain in pregnancy. Notable publications co-authored by Dr Donald include "Effectiveness of smoking cessation pharmacotherapies during pregnancy: A multi-national population-based study" (Addiction, 2025, with A.L. Robijn et al.), "Risk of major congenital malformations following prenatal exposure to smoking cessation medicines" (JAMA Internal Medicine, 2025, with D.T. Tran et al.), "Global trends in analgesic opioid use in pregnancy: A retrospective cohort study" (Anesthesiology, 2025, with J. Brett et al.), "Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005–2015" (Pharmacoepidemiology and Drug Safety, 2020), and "Antidepressant dispensing before, during, and after pregnancy in New Zealand, 2005-2014" (Australian and New Zealand Journal of Obstetrics and Gynaecology, 2021). Through her involvement in multinational collaborations, Dr Donald's work informs evidence-based practices on medication safety for pregnant populations, enhancing public health outcomes.